1-4 of 4
G Schernthaner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Diabetes Care 2013;36:2508–2515

G Schernthaner, JL Gross, J Rosenstock, M Guarisco, M Fu, J Yee, M Kawaguchi, W Canovatchel, G Meininger
Journal: Diabetes Care
Diabetes Care 2013;36(12):4172
https://doi.org/10.2337/dc13-er12a
Published: 13 November 2013
View articletitled, Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Diabetes Care 2013;36:2508–2515
Open the PDF for Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Diabetes Care 2013;36:2508–2515 in another window
Meeting Abstracts

Magnesium supplementation in type 2 diabetes.

N Eibl, C Schnack, G Schernthaner
Journal: Diabetes Care
Diabetes Care 1998;21(11):2031–2032
https://doi.org/10.2337/diacare.21.11.2031
Published: 01 November 1998
View articletitled, Magnesium supplementation in type 2 diabetes.
Open the PDF for Magnesium supplementation in type 2 diabetes. in another window
Journal Articles

The Efficacy and Safety of Miglitol Therapy Compared With Glibenclamide in Patients With NIDDM Inadequately Controlled by Diet Alone

P Segal, MD, PU Feig, MD, G Schernthaner, MD, KP Ratzmann, MD, J Rybka, MD, D Petzinna, MD, C Berlin, DIPL, MATH
Journal: Diabetes Care
Diabetes Care 1997;20(5):687–691
https://doi.org/10.2337/diacare.20.5.687
Published: 01 May 1997
View articletitled, The Efficacy and Safety of Miglitol Therapy Compared With Glibenclamide in Patients With NIDDM Inadequately Controlled by Diet Alone
Open the PDF for The Efficacy and Safety of Miglitol Therapy Compared With Glibenclamide in Patients With NIDDM Inadequately Controlled by Diet Alone in another window
Journal Articles

Immediate-Type Allergy Against Insulin Itself: Clinical and Immunologic Studies on a Diabetic Patient with Insulin Intolerance

G Schernthaner, H Ludwig, R Jarisch, H Bruneder
Journal: Diabetes Care
Diabetes Care 1981;4(2):196–201
https://doi.org/10.2337/diacare.4.2.196
Published: 01 March 1981
View articletitled, Immediate-Type Allergy Against Insulin Itself: Clinical and Immunologic Studies on a Diabetic Patient with Insulin Intolerance
Open the PDF for Immediate-Type Allergy Against Insulin Itself: Clinical and Immunologic Studies on a Diabetic Patient with Insulin Intolerance in another window